Skeletal-related events occurred in 38% of patients with metastatic castration-resistant prostate cancer.
Skeletal-Related Events Predict Higher Mortality in mCRPC


Skeletal-related events occurred in 38% of patients with metastatic castration-resistant prostate cancer.